TY  - JOUR

T1  - Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.

JO  - J Thromb Haemost

PY  - 2010/05/21

AU  - Judge HM

AU  - Patil SB

AU  - Buckland RJ

AU  - Jakubowski JA

AU  - Storey RF

ED  - 

DO  - DOI: 10.1111/j.1538-7836.2010.03925.x

VL  - 8

IS  - 8

SP  - 1820

EP  - 1827

Y2  - 2024/12/28

ER  -